Prostate Cancer Affects 1 in 8 Men.

Qdata® Can Help Enhance Their Treatment.

Qdata Prostate Cancer is an exclusive, real-world dataset of 364,000 patients with curated variables such as Gleason score and castration resistance to help you better understand the patient journey.

About Qdata

Qdata® by Verana Health are research ready, fit-for-purpose data modules designed to confidently drive business insights and inform research outcomes. Qdata spans ophthalmology, neurology, and urology to help unlock quality insights across the entire drug and device development cycle.

animated magnifying glass icon

Exclusive Insights into the Prostate Cancer Population

Only found here from the American Urological Association AQUA Registry

animated kidney and bladder icon

Unique Understanding of Disease Progression

View prostate cancer biomarkers such as PSA level or Gleason score

animated person atop arrow icon

Earlier View into the Prostate Cancer Patient Journey

Insight into treatment path choices from urologist EHRs


By the Numbers


Contributing Urologists


Total patients with prostate cancer with linked claims**


Average length of follow-up data with linked claims

Colorful Abstract

*Defined as patients in AQUA Registry who have (1) either of the "Malignant neoplasm of prostate" ICD codes (ICD-9-CM 185 or ICD-10-CM C61); AND (2) a Gleason score of 6 or above.

**Year > 2015 linked with open or closed Komodo Health medical/pharmacy claims data with minimum 1 claim. Data Current to January 2023.

Meet with a Qdata Expert or Request a Data Count

Key Variables in Qdata Prostate Cancer

Curated variables are extracted from EHR data to be utilized based on your research needs.

Gleason Score

PSA Level

TNM Stage

Testosterone Level

Castration Resistance


Unstructured Data Enables Deeper Understanding

Verana Health applies clinician-informed algorithms to unstructured EHR data at scale to help extract key information on PSA levels, Gleason scores, castration resistance, and other key variables, which can then be analyzed across large populations in a reliable manner.

This can give life science companies unprecedented insights into the journey of patients with prostate cancer.


of Medical Data Remains Unstructured


Talk to a Qdata Expert

Take a minute to submit your contact information and one of our team members will reach out to you.